06:32 EDT J&J’s LLT proposes to resolve all ovarian cancer talc claims via reorganization
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- J&J receives positive CHMP opinion recommending approval of Sirturo in MDR TB
- LLY vs. JNJ: Which Big Pharma Stock Is Better?
- Cidara Therapeutics reacquires rights to CD388 from Johnson & Johnson for $85M
- Johnson & Johnson management to meet with Oppenheimer
- Legend Biotech says Carvykti approved by EC for second-line multiple myeloma
